Sponsor

Janssen Scientific Affairs, LLC

Clinical research sponsor

Published trials53
Recruiting shown4
Roles2
SourceClinicalTrials.gov

Clinical trials

53 shown
A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight GainNCT04442737 · lead sponsor · 2020-07-01
COMPLETED
A Study to Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of CareNCT03227861 · lead sponsor · 2017-07-31
COMPLETED
Sustainable Early Episode Clinic Study (SEEC)NCT03571685 · lead sponsor · 2017-01-31
COMPLETED
Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid ArthritisNCT02728934 · lead sponsor · 2016-02-25
COMPLETED
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) TolerabilityNCT02663193 · lead sponsor · 2015-12-01
COMPLETED
Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)NCT02600741 · lead sponsor · 2015-07-24
COMPLETED
A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or SchizophreniformNCT02431702 · lead sponsor · 2015-07-08
COMPLETED
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive AgentsNCT01939496 · lead sponsor · 2013-10-01
COMPLETED
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective DisorderNCT01193153 · lead sponsor · 2010-09-01
COMPLETED
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health OrganizationsNCT01181960 · lead sponsor · 2010-08-01
COMPLETED
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and IncarceratedNCT01157351 · lead sponsor · 2010-05-01
COMPLETED
A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant WomenNCT00855335 · lead sponsor · 2009-04-09
COMPLETED
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.NCT06274047 · collaborator · 2024-09-10
RECRUITING
Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE TrialNCT06067269 · collaborator · 2024-03-28
RECRUITING
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic LymphomaNCT04139304 · collaborator · 2021-05-24
RECRUITING
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.NCT00404989 · collaborator · 1989-01-01
RECRUITING
177Lu-PSMA, Niraparib/AA Plus Prednisone for Prostate CancerNCT06329830 · collaborator · 2024-10-01
WITHDRAWN
Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP StudyNCT05960578 · collaborator · 2024-05-23
ACTIVE_NOT_RECRUITING
High-Risk Metachronous Oligometastatic Prostate Cancer TrialNCT06212583 · collaborator · 2024-04-17
ACTIVE_NOT_RECRUITING
Effect of Biktarvy & Symtuza on microRNAs in HIV and Correlation With Weight GainNCT05463783 · collaborator · 2023-03-14
UNKNOWN
Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate CancerNCT04926181 · collaborator · 2022-03-16
TERMINATED
A Study of Amivantamab and Lazertinib in People With Non-Small Cell Lung Cancer (NSCLC)NCT04965090 · collaborator · 2021-09-30
COMPLETED
Rapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART)NCT04388904 · collaborator · 2021-09-01
COMPLETED
Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to DaratumumabNCT04270175 · collaborator · 2021-04-14
ACTIVE_NOT_RECRUITING
Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat MetabolismNCT04675255 · collaborator · 2021-01-01
COMPLETED
Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate CancerNCT02811809 · collaborator · 2020-12-01
WITHDRAWN
A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate CancerNCT04194554 · collaborator · 2020-11-06
ACTIVE_NOT_RECRUITING
Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate CancerNCT04267887 · collaborator · 2020-05-11
ACTIVE_NOT_RECRUITING
Conventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADTNCT03777982 · collaborator · 2020-04-20
TERMINATED
Study of Daratumumab in Patients With Mild to Moderate Alzheimer's DiseaseNCT04070378 · collaborator · 2019-11-06
COMPLETED
Assessment of Biomarkers in Patients With Decompensated Heart Failure and Underlying Coronary Artery DiseaseNCT03551756 · collaborator · 2018-07-10
UNKNOWN
Apalutamide in Treating Patients With Prostate Cancer Who Are in Active SurveillanceNCT02721979 · collaborator · 2017-11-02
TERMINATED
Effects of Canagliflozin on Intravascular Volume and HemodynamicsNCT03190798 · collaborator · 2017-09-01
WITHDRAWN
Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate CancerNCT03098836 · collaborator · 2017-07-10
COMPLETED
A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomyNCT02849990 · collaborator · 2017-03-09
COMPLETED
CARAT: Canagliflozin vs. Placebo for Post Bariatric Patients With Persistent Type 2 DiabetesNCT02912455 · collaborator · 2017-01-05
TERMINATED
Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPCNCT02913196 · collaborator · 2016-12-30
COMPLETED
Study of Ibrutinib Followed by Ibrutinib in Combination With Nivolumab in Non-Small Cell Lung Cancer (NSCLC)NCT02950038 · collaborator · 2016-12-01
WITHDRAWN
Role of Canagliflozin on CD34+ Cells in Patients With Type 2 DiabetesNCT02964585 · collaborator · 2016-11-01
COMPLETED
Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing ProstatectomyNCT02903368 · collaborator · 2016-10-19
COMPLETED
Treatment of Diabetes in Patients With Systolic Heart FailureNCT02920918 · collaborator · 2016-10-01
COMPLETED
Darunavir/Cobicistat and Dolutegravir to Maintain Virologic Suppression and Reduce NRTI-associated ToxicityNCT02499978 · collaborator · 2016-05-01
WITHDRAWN
Canagliflozin-Mealtime Insulin RescueNCT02624908 · collaborator · 2016-01-01
UNKNOWN
Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer CenterNCT02502396 · collaborator · 2015-09-28
COMPLETED
Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve SubjectsNCT02404233 · collaborator · 2015-03-01
UNKNOWN
Mechanisms of Weight Loss With SGLT2 InhibitionNCT02360774 · collaborator · 2015-02-01
COMPLETED
Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic PatientsNCT02324842 · collaborator · 2014-11-01
COMPLETED
A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis CNCT02206932 · collaborator · 2014-08-01
WITHDRAWN
3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical ProstatectomyNCT01751451 · collaborator · 2012-12-18
COMPLETED
Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode SchizophreniaNCT01451736 · collaborator · 2011-10-01
COMPLETED
Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted TherapiesNCT01254864 · collaborator · 2011-03-16
COMPLETED
Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset SchizophreniaNCT00333177 · collaborator · 2006-03-01
COMPLETED
Oral Versus Injectable Risperidone for Treating First-Episode SchizophreniaNCT00330551 · collaborator · 2006-03-01
COMPLETED

Sponsor roles

collaborator41
lead sponsor12

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.